FdaApplication
ANDA 219194
Identifiers
- fda_app_no: ANDA219194
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2025-02-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACETYLCYSTEINE | ACETYLCYSTEINE | 20% | SOLUTION;INHALATION, ORAL |
| ACETYLCYSTEINE | ACETYLCYSTEINE | 10% | SOLUTION;INHALATION, ORAL |
2 products